tiprankstipranks
Trending News
More News >
Adverum Biotechnologies: Promising Gene Therapy Developments and Financial Stability Justify Buy Rating
PremiumRatingsAdverum Biotechnologies: Promising Gene Therapy Developments and Financial Stability Justify Buy Rating
2M ago
Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress
2M ago
Adverum Biotechnologies reports Q4 EPS ($1.96), consensus ($1.38)
Premium
The Fly
Adverum Biotechnologies reports Q4 EPS ($1.96), consensus ($1.38)
2M ago
ADVM Earnings this Week: How Will it Perform?
PremiumPre-EarningsADVM Earnings this Week: How Will it Perform?
3M ago
Adverum Biotechnologies initiates ARTEMIS study
Premium
The Fly
Adverum Biotechnologies initiates ARTEMIS study
4M ago
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
Premium
The Fly
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
4M ago
Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
PremiumThe FlyAdverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
8M ago
Is ADVM a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADVM a Buy, Before Earnings?
8M ago
Adverum Biotechnologies Advances in Gene Therapy Development
Premium
Company Announcements
Adverum Biotechnologies Advances in Gene Therapy Development
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100